Expression, purification and characterization of the extracellular domain of human Flt3 ligand in Escherichia coli
- 20 August 2009
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 37 (5) , 2301-2307
Abstract
Fms-like tyrosine kinase 3 ligand (Flt3 ligand, FL) is a cytokine that affects the growth, survival and/or differentiation of hematopoietic cells through the activation of specific tyrosine kinase receptors, and is potentially useful for in vitro HSC amplification. To express the extracellular domain of human Flt3 ligand (hFLext) in Escherichia coli, we cloned hFLext and constructed the recombinant expression vector pET32a-hFLext. hFLext was successfully expressed in E. coli as a Trx fusion protein (Trx-hFLext) under IPTG (isopropyl-β-d-thiogalactopyranoside) induction for 12 h at 30°C. The Trx-hFLext protein, expressed in inclusion bodies even at a low induction temperature, was successfully refolded and purified using dialysis and affinity chromatography. The purified hFLext was biologically active and could effectively stimulate the proliferation of mouse bone marrow nucleated cells revealed by cell proliferation assay and colony forming assay. In addition, in synergize with G-CSF and TPO, recombinant purified hFLext could stimulate ex vivo expansion of murine Lin−Sca-1+c-Kit+ cells. Therefore, using the E. coli expression system and an affinity chromatography system, we successfully expressed, refolded, and purified a biologically active Trx-hFLext protein which might be potentially useful for in vitro HSC amplification.Keywords
This publication has 22 references indexed in Scilit:
- FLT3 receptor and ligand are dispensable for maintenance and posttransplantation expansion of mouse hematopoietic stem cellsBlood, 2009
- Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: Utilization for ovarian cancer treatmentOncology Reports, 2008
- Estradiol Acts Directly on Bone Marrow Myeloid Progenitors to Differentially Regulate GM-CSF or Flt3 Ligand-Mediated Dendritic Cell DifferentiationThe Journal of Immunology, 2008
- Flt3-L gene therapy enhances immunocytokine-mediated antitumor effects and induces long-term memoryCancer Immunology, Immunotherapy, 2007
- Mini ReviewFLT3: Receptor and LigandGrowth Factors, 2004
- Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesisBlood, 2001
- Expression of Human Flt3 Ligand in Pichia pastoris and Its Biological Characteristics.2000
- FLT3: Receptor and Ligand. Biology and Potential Clinical ApplicationCytokine & Growth Factor Reviews, 1998
- Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAsNature, 1994
- Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cellsCell, 1993